Redefining Counterfeit Medicines and Updating the Legal Framework to Address Falsified Medicines: A Qualitative Policy Review
There is a clear need to update the regulatory framework on counterfeit medicines which would entail revisiting RA 8203 to amend the definition of counterfeit medicines and other related provisions in alignment with the WHO definitions.
Authors
- Roderick L. Salenga
- Yolanda Robles
- Bryan Paul I. Bulatao (ORCID: https://orcid.org/0000-0002-5436-8447)
- Francis R Capule (ORCID: https://orcid.org/0000-0003-2468-9095)
- Monet M. Loquias
- Imelda G Peña
- Jean Flor C Casauay
Institutions
- University of the Philippines Manila (PH)
Publication Details
- Journal
- Acta Medica Philippina
- Published
- 2025-01-01
- DOI
- https://doi.org/10.47895/amp.v59i14.9562
- Citations
- 1
- Primary Topic
- Pharmaceutical Quality and Counterfeiting
- Type
- article
- Field-Weighted Citation Impact
- 1.88